Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
Background: In the SOD1G93A mutant rat model of amyotrophic lateral sclerosis (ALS), neuronal death and rapid paralysis progression are associated with the emergence of activated aberrant glial cells that proliferate in the degenerating spinal cord. Whether pharmacological downregulation of such abe...
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Бусад зохиолчид: | , , , , , , , , , , , , , |
| Формат: | article |
| Хэл сонгох: | англи |
| Хэвлэсэн: |
2016
|
| Нөхцлүүд: | |
| Онлайн хандалт: | http://hdl.handle.net/20.500.12381/169 http://dx.doi.org/10.1186/s12974-016-0620-9 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс: Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
- Neuroprotective effects of violacein in a model of inherited amyotrophic lateral sclerosis
- Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis
- The pathogenic role of c‑Kit+ mast cells in the spinal motor neuron‑vascular niche in ALS
- The neuromelanin paradox and its dual role in oxidative stress and neurodegeneration
- Generation and Characterization of Stable Redox-Reporter Mammalian Cell Lines of Biotechnological Relevance
- Sunitinib-containing carborane pharmacophore with the ability to inhibit tyrosine kinases receptors FLT3, KIT and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity